Use of Dermocosmetics in Acne Management: A Middle East-North Africa Consensus

Acne in the Middle East and Northern Africa (MENA) is associated with high rates of post-inflammatory hyperpigmentation and scarring, resulting from relatively high frequencies of darker or oily skin types, environmental factors, perceptions, and knowledge of acne and its treatment. Dermocosmetics, over-the-counter products with bioactive ingredients, can enhance acne management. The aim of this consensus was to provide recommendations for the integration of dermocosmetics into acne management plans in the MENA region.

A group of eight key opinion leaders from the MENA region generated three consensus recommendations supporting the role of dermocosmetics in acne management using the Delphi methodology. Information on cases relating to the use of dermocosmetics as adjuncts in acne management was also presented.

Consensus was reached for all three recommendations relating to the use of dermocosmetics in acne management, including the use of dermocosmetics as monotherapy for mild acne cases and as adjuncts to acne medications to improve tolerability and efficacy of medications and to enhance treatment adherence. The two illustrative cases presented support the use of dermocosmetics as adjuncts in acne management.

Cleansers, moisturizers, and photoprotection are important aspects of acne management, and both clinicians and patients should be aware of the benefits they can provide. Dermocosmetics are recommended to be used as monotherapy for mild acne or maintenance following active treatment as well as adjuncts to acne medications to improve effectiveness and tolerance of acne treatment. Education and awareness are key to the successful incorporation of appropriate dermocosmetics into acne management.